325 related articles for article (PubMed ID: 17184724)
21. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
Ingallinella P; Altamura S; Bianchi E; Taliani M; Ingenito R; Cortese R; De Francesco R; Steinkühler C; Pessi A
Biochemistry; 1998 Jun; 37(25):8906-14. PubMed ID: 9636032
[TBL] [Abstract][Full Text] [Related]
22. In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates.
Khumthong R; Angsuthanasombat C; Panyim S; Katzenmeier G
J Biochem Mol Biol; 2002 Mar; 35(2):206-12. PubMed ID: 12297031
[TBL] [Abstract][Full Text] [Related]
23. Internally quenched fluorescent peptide libraries with randomized sequences designed to detect endopeptidases.
Oliveira LC; Silva VO; Okamoto DN; Kondo MY; Santos SM; Hirata IY; Vallim MA; Pascon RC; Gouvea IE; Juliano MA; Juliano L
Anal Biochem; 2012 Feb; 421(1):299-307. PubMed ID: 22067978
[TBL] [Abstract][Full Text] [Related]
24. Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Protein Expr Purif; 2007 May; 53(1):87-96. PubMed ID: 17174105
[TBL] [Abstract][Full Text] [Related]
25. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
Yin Z; Patel SJ; Wang WL; Wang G; Chan WL; Rao KR; Alam J; Jeyaraj DA; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
Bioorg Med Chem Lett; 2006 Jan; 16(1):36-9. PubMed ID: 16246553
[TBL] [Abstract][Full Text] [Related]
26. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
27. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro.
Yusof R; Clum S; Wetzel M; Murthy HM; Padmanabhan R
J Biol Chem; 2000 Apr; 275(14):9963-9. PubMed ID: 10744671
[TBL] [Abstract][Full Text] [Related]
28. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
[TBL] [Abstract][Full Text] [Related]
29. Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease.
Lin CW; Huang HD; Shiu SY; Chen WJ; Tsai MH; Huang SH; Wan L; Lin YJ
Virus Res; 2007 Jul; 127(1):88-94. PubMed ID: 17467838
[TBL] [Abstract][Full Text] [Related]
30. Nardilysin cleaves peptides at monobasic sites.
Chow KM; Oakley O; Goodman J; Ma Z; Juliano MA; Juliano L; Hersh LB
Biochemistry; 2003 Feb; 42(7):2239-44. PubMed ID: 12590613
[TBL] [Abstract][Full Text] [Related]
31. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
32. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates.
Taliani M; Bianchi E; Narjes F; Fossatelli M; Urbani A; Steinkühler C; De Francesco R; Pessi A
Anal Biochem; 1996 Aug; 240(1):60-7. PubMed ID: 8811880
[TBL] [Abstract][Full Text] [Related]
33. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.
Shiryaev SA; Kozlov IA; Ratnikov BI; Smith JW; Lebl M; Strongin AY
Biochem J; 2007 Feb; 401(3):743-52. PubMed ID: 17067286
[TBL] [Abstract][Full Text] [Related]
34. Activity of human kallikrein-related peptidase 6 (KLK6) on substrates containing sequences of basic amino acids. Is it a processing protease?
Silva RN; Oliveira LCG; Parise CB; Oliveira JR; Severino B; Corvino A; di Vaio P; Temussi PA; Caliendo G; Santagada V; Juliano L; Juliano MA
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):558-564. PubMed ID: 28254587
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.
Nall TA; Chappell KJ; Stoermer MJ; Fang NX; Tyndall JD; Young PR; Fairlie DP
J Biol Chem; 2004 Nov; 279(47):48535-42. PubMed ID: 15322074
[TBL] [Abstract][Full Text] [Related]
36. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain.
Shannon AE; Chappell KJ; Stoermer MJ; Chow SY; Kok WM; Fairlie DP; Young PR
Protein Expr Purif; 2016 Mar; 119():124-9. PubMed ID: 26647367
[TBL] [Abstract][Full Text] [Related]
38. Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease.
de la Cruz L; Chen WN; Graham B; Otting G
FEBS J; 2014 Mar; 281(6):1517-33. PubMed ID: 24472363
[TBL] [Abstract][Full Text] [Related]
39. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of the NS2B/NS3 protease complex from seven viruses belonging to different groups inside the genus Flavivirus.
Bessaud M; Pastorino BA; Peyrefitte CN; Rolland D; Grandadam M; Tolou HJ
Virus Res; 2006 Sep; 120(1-2):79-90. PubMed ID: 16504332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
